ChinaDaily Briefs

Daily Brief China: Tencent, Shanghai Junshi Biosciences , ENM Holdings, S.F. Holding and more

In today’s briefing:

  • Last Week In Event SPACE: Vingroup/VinFast, Prosus/Naspers, STAR CM
  • China Healthcare Weekly (Sep.1) – China’s New IPO Reform, Financing Environment, Junshi Biosciences
  • ECM Weekly (3rd Sep 2023) – Doosan, VNG, Tuhu, Integral, ARM, Zomato, APM, Auckland Int, Daiwa REIT
  • 26 Sept Scheme Vote For ENM (128 HK)
  • SF Holding HK IPO | Q2/H1 Results | “Internationalization” Thesis Refined | Air, Int’l Impact in H1


Last Week In Event SPACE: Vingroup/VinFast, Prosus/Naspers, STAR CM

By David Blennerhassett

  • Marginal float helped fuel the VinFast (VFS US) bubble. Then it popped. 
  • The Prosus (PRX NA)/Naspers (NPN SJ) Circularity Detour and subsequent unwind created the B-Share construct which means they can maintain the voting control in South Africa without maintaining economic control.
  • The backlash against Star CM Holdings (6698 HK) calls into question the broader Chinese entertainment industry, and how it strikes a balance between viewership/profitability and ethical boundaries.

China Healthcare Weekly (Sep.1) – China’s New IPO Reform, Financing Environment, Junshi Biosciences

By Xinyao (Criss) Wang

  • IPO rules in SSE STAR Market faces adjustments, so investors have lowered expectations, which will affect the fundraising ecology. Recovery of China’s financing environment would be slower than US/Europe.
  • The CSRC has issued new policies related to stamp duty, IPO, and reduction of shares held by listed companies, which would significantly affect the capitalization path of pharmaceutical companies.
  • Junshi is “an interesting Biotech” that once generated sales/profits in scale, but is losing money again.Since Junshi is outside the first echelon and the gap is widening, we remain conservative. 

ECM Weekly (3rd Sep 2023) – Doosan, VNG, Tuhu, Integral, ARM, Zomato, APM, Auckland Int, Daiwa REIT

By Sumeet Singh


26 Sept Scheme Vote For ENM (128 HK)

By David Blennerhassett

  • Back on the 2 June, small-cap fashion wear retailer ENM Holdings (128 HK) received a delisting Offer from major shareholder, Chinachem, at HK$0.58/share, in cash.
  • The Scheme Doc is now out after thrice being delayed. The EGM/Court Meeting will be held on the 26 September with expected payment around the 14 November. 
  • There’s a whiff of opportunism embedded in the Offer. But being loss-making and illiquid, I’d expect the vote to still get up.

SF Holding HK IPO | Q2/H1 Results | “Internationalization” Thesis Refined | Air, Int’l Impact in H1

By Daniel Hellberg

  • Review of Q2/H1 results, including impact from international, Kerry Logistics Network
  • Refining idea of “internationalization”, which we believe is driving force behind SF’s HK IPO
  • Testing thesis: did air and international exposure help or hurt SF margins in H1?

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars